ABVC Biopharma Inc (ABVC)vsRevolution Medicines Inc (RVMD)
ABVC
ABVC Biopharma Inc
$0.98
+0.40%
HEALTHCARE · Cap: $25.85M
RVMD
Revolution Medicines Inc
$203.77
+0.21%
HEALTHCARE · Cap: $44.44B
Smart Verdict
WallStSmart Research — data-driven comparison
ABVC Biopharma Inc generates 8% more annual revenue ($797,920 vs $742,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. ABVC earns a higher WallStSmart Score of 29/100 (F).
ABVC
Avoid29
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+66.7%
Fair Value
$5.20
Current Price
$0.98
$4.22 discount
Intrinsic value data unavailable for RVMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 104.5% year-over-year
Conservative balance sheet, low leverage
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Operating margin of 0.0%
Trading at 16.8x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : ABVC
The strongest argument for ABVC centers on Revenue Growth, Debt/Equity, Price/Book. Revenue growth of 104.5% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : ABVC
The primary concerns for ABVC are EPS Growth, Market Cap, Profit Margin.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
ABVC profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
ABVC is growing revenue faster at 104.5% — sustainability is the question.
ABVC generates stronger free cash flow (-488,826), providing more financial flexibility.
Bottom Line
ABVC scores higher overall (29/100 vs 24/100) and 104.5% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
ABVC Biopharma Inc
HEALTHCARE · BIOTECHNOLOGY · USA
American BriVision (Holding) Corporation, a clinical-stage biopharmaceutical company, develops drugs and medical devices to meet unmet medical needs in the United States.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?